Net Sales Margin: Paragon 28, Inc. (FNA)

Official company branding of paragon28.com (FNA)

The Paragon 28, Inc. (FNA) implant ecosystem ensures total physician loyalty through unique surgical protocols. Strong pricing power is sustained by a vast catalog of specialized instruments, as evidenced by the current net profit margin illustrated in this chart by the GURU.Markets system; the parameter has stabilized at -21.30. Business growth is driven by joint educational programs with orthopedic surgeons and innovative developments.

Paragon 28 (FNA) - Net Sales Margin from 07/04/2022 to 04/26/2025

paragon28.com (FNA) - metric breakdowns and financial figures

- share price and expert price forecast:
Comprehensive company analysis:Paragon 28, Inc.
Finished products of Paragon 28, Inc.

The market assesses the investment potential of Paragon 28, Inc. (FNA) through the business's ability to convert revenue into net income. This metric measures the remaining funds after deducting all operating and tax liabilities. By analyzing net profit per unit of revenue, an investor can gauge cost management efficiency. The production of highly specialized implants creates operating leverage, reducing unit costs as volumes grow. The asset belongs to the high-tech medical business class.

Competitors of Paragon 28, Inc.

BSX: Net Sales Margin|Return on Sales by Net Profit Edwards Lifesciences Corporation|RMD (ResMed Corporation) - Net Sales Margin|OmniPod (PODD) - Company Sales Margin|Net Sales Margin ZBH|Net Sales Margin coopercos.com (COO)|Net Sales Margin ALGN (aligntech.com)|Net Sales Margin Globus Medical Inc GMED|TMDX - Net Margin|ATEC: Net Margin|AORT (Artivion, Inc.) - Return on Sales by Net Profit|Enovis Corporation - Net Profit Rate|IART (Integra LifeSciences Inc.) - Net Sales Margin|Net Margin Establishment Labs Corp ESTA|Net Margin Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Net Profitability Margin|Embecta Health - Return on Sales by Net Profit|Net Sales Margin Tandem Diabetes Care TNDM|AxoGen Inc - Net Sales Margin|Company Sales Margin SI-BONE Inc SIBN|Orthofix (OFIX) - Net Margin|Return on Sales by Net Profit Bioventus Corp|Net Margin orthopediatrics.com|Return on Sales by Net Profit Treace Medical Concepts (TMCI)|Net Sales Margin SRTA|CARL - Net Margin|Net Margin RxSight, Inc. RXST|CLPT: Net Return on Sales|STXS: Return on Sales by Net Profit|neurostar.com - Company Net Profitability|Sight Sciences Inc. (SGHT) - Net Margin|Net Margin orchestrabiomed.com (OBIO)|Net Margin Anika Therapeutics, Inc.|Net Return on Sales NSPR (InspireMD Inc.)|Net Margin Jin Medical International Ltd (ZJYL)|Net Margin VANI (Vivani Medical)|Net Margin xtantmedical.com XTNT|Net Profit Rate NMTC|MODD - Net Margin|Net Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Sales by Net Profit|Vivos Therapeutics, Inc. - Net Profit Rate|Net Margin enVVeno Corp|SINT (Sintx Technologies) - Company Net Profitability|Net Sales Margin TNON|LFWD (Lifeward Ltd.) - Net Profit Rate|autonomix.com - Return on Sales by Net Profit|Company Sales Margin invobioscience.com (IVF)|BBLG - Net Margin|AXNX (Axonics) - Net Return on Sales|BIOL: Net Sales Margin|DYNT - Company Sales Margin|INVO (INVO Bioscience Inc.) - Net Sales Margin